COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
University of Cambridge > Talks.cam > Early Cancer Institute Seminar Series > Early Detection Programme Launch event
Early Detection Programme Launch eventAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Catherine Atkins. For catering purposes please sign up at http://www.eventbrite.com/e/cambridge-cancer-centre-early-detection-programme-launch-tickets-19040002159 The Cambridge Cancer Centre has established an Early Detection programme as a key priority and it is with great pleasure that we announce the launch of this programme. Dr Harpal Kumar, CEO of Cancer Research UK, will speak about the importance of early detection for Cancer Research UK and Professor Sir Peter Gregson (Vice Chancellor, Cranfield University) will address the audience about the importance of cross-disciplinary research, as well as his own personal experience of an early cancer diagnosis. Newly funded early detection research projects will also be presented. Professor Sir Leszek Borysiewicz, Vice Chancellor, University of Cambridge, will deliver the concluding remarks. The event starts 3pm with tea/coffee and a drinks reception will follow the talks, around 6pm. For catering purposes if you would like to come please sign up at http://www.eventbrite.com/e/cambridge-cancer-centre-early-detection-programme-launch-tickets-19040002159 or for further information email cja52@cam.ac.uk This talk is part of the Early Cancer Institute Seminar Series series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsCRASSH-Festival of Ideas CU Labour Club: All Events ims-mrl external research seminar First Intestinal Epithelial Research Symposium SPI III Pint of KnowledgeOther talksViral infection dynamics in transplant recipients undergoing immunosuppression The role of transcription factors in cancer MOVED TO 28 JUNE 2018 It takes two to tango:platelet collagen receptor GPVI-dimer in thrombosis and clinical implications The MHC ligandome of two contagious cancers within the Tasmanian devil population, Devil Facial Tumour 1 and Devil Facial Tumour 2 |